Last updated on August 2020

Evaluation of the Frequency of Occurrence of Joint Pain With Bevacizumab in Patients With Ovarian Colorectal or Bronchopulmonary Cancer


Brief description of study

Self-administered questionnaire survey to determine the presence or absence of joint pain during bevacizumab treatment for lung, ovarian, colorectal cancers.

The principal end-point is the frequency of arthralgia after 6 months of treatment with Bevacizumab.

Clinical Study Identifier: NCT03455907

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.